ICSMA-18-142-01
Vulnerability from csaf_cisa - Published: 2018-05-22 00:00 - Updated: 2018-10-11 00:00Summary
BD Kiestra and InoquIA Systems (Update A)
Notes
CISA Disclaimer
This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov
Legal Notice
All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.
Risk evaluation
Successful exploitation of these vulnerabilities may lead to loss or corruption of data.
Critical infrastructure sectors
Healthcare and Public Health
Countries/areas deployed
Worldwide
Company headquarters location
United States
Recommended Practices
NCCIC recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities. Specifically, users should:
Recommended Practices
NCCIC reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
Recommended Practices
NCCIC also provides a section for control systems security recommended practices on the ICS-CERT web page. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Recommended Practices
Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to NCCIC for tracking and correlation against other incidents.
Recommended Practices
NCCIC also recommends that users take the following measures to protect themselves from social engineering attacks:
Recommended Practices
Additional mitigation guidance and recommended practices are publicly available on the ICS-CERT website in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.
Exploitability
No known public exploits specifically target these vulnerabilities. These vulnerabilities are not exploitable remotely. High skill level is needed to exploit.
{
"document": {
"acknowledgments": [
{
"names": [
"BD"
],
"summary": "discovering these vulnerabilities and reporting them to NCCIC"
}
],
"category": "csaf_security_advisory",
"csaf_version": "2.0",
"distribution": {
"text": "Disclosure is not limited",
"tlp": {
"label": "WHITE",
"url": "https://us-cert.cisa.gov/tlp/"
}
},
"lang": "en-US",
"notes": [
{
"category": "general",
"text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
"title": "CISA Disclaimer"
},
{
"category": "legal_disclaimer",
"text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
"title": "Legal Notice"
},
{
"category": "summary",
"text": "Successful exploitation of these vulnerabilities may lead to loss or corruption of data.",
"title": "Risk evaluation"
},
{
"category": "other",
"text": "Healthcare and Public Health",
"title": "Critical infrastructure sectors"
},
{
"category": "other",
"text": "Worldwide",
"title": "Countries/areas deployed"
},
{
"category": "other",
"text": "United States",
"title": "Company headquarters location"
},
{
"category": "general",
"text": "NCCIC recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities. Specifically, users should:",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "NCCIC reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "NCCIC also provides a section for control systems security recommended practices on the ICS-CERT web page. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to NCCIC for tracking and correlation against other incidents.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "NCCIC also recommends that users take the following measures to protect themselves from social engineering attacks:",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "Additional mitigation guidance and recommended practices are publicly available on the ICS-CERT website in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.",
"title": "Recommended Practices"
},
{
"category": "other",
"text": "No known public exploits specifically target these vulnerabilities. These vulnerabilities are not exploitable remotely. High skill level is needed to exploit.",
"title": "Exploitability"
}
],
"publisher": {
"category": "coordinator",
"contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
"name": "CISA",
"namespace": "https://www.cisa.gov/"
},
"references": [
{
"category": "self",
"summary": "ICS Advisory ICSMA-18-142-01 JSON",
"url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2018/icsma-18-142-01.json"
},
{
"category": "self",
"summary": "ICS Advisory ICSMA-18-142-01 Web Version",
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-18-142-01"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-18-142-01"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.cisa.gov/uscert/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
}
],
"title": "BD Kiestra and InoquIA Systems (Update A)",
"tracking": {
"current_release_date": "2018-10-11T00:00:00.000000Z",
"generator": {
"engine": {
"name": "CISA CSAF Generator",
"version": "1.0.0"
}
},
"id": "ICSMA-18-142-01",
"initial_release_date": "2018-05-22T00:00:00.000000Z",
"revision_history": [
{
"date": "2018-05-22T00:00:00.000000Z",
"legacy_version": "Initial",
"number": "1",
"summary": "ICSMA-18-142-01 BD Kiestra and InoquIA Systems"
},
{
"date": "2018-10-11T00:00:00.000000Z",
"legacy_version": "A",
"number": "2",
"summary": "ICSMA-18-142-01 BD Kiestra and InoquIA Systems (Update A)"
}
],
"status": "final",
"version": "2"
}
},
"product_tree": {
"branches": [
{
"branches": [
{
"branches": [
{
"category": "product_version",
"name": "3.0.1.0",
"product": {
"name": "Database (DB) Manager: Version 3.0.1.0",
"product_id": "CSAFPID-0001"
}
}
],
"category": "product_name",
"name": "Database (DB) Manager"
},
{
"branches": [
{
"category": "product_version_range",
"name": "\u003c=3.0.0.0",
"product": {
"name": "BD Kiestra TLA WCA InoqulA+ speciman processor - PerformA: Version 3.0.0.0 and previous versions",
"product_id": "CSAFPID-0002"
}
}
],
"category": "product_name",
"name": "BD Kiestra TLA WCA InoqulA+ speciman processor - PerformA"
},
{
"branches": [
{
"category": "product_version",
"name": "3.0.1.0",
"product": {
"name": "BD Kiestra TLA WCA InoqulA+ speciman processor - Database (DB) Manager: Version 3.0.1.0",
"product_id": "CSAFPID-0003"
}
}
],
"category": "product_name",
"name": "BD Kiestra TLA WCA InoqulA+ speciman processor - Database (DB) Manager"
},
{
"branches": [
{
"category": "product_version_range",
"name": "\u003c=1.1.0.2",
"product": {
"name": "BD Kiestra TLA WCA InoqulA+ speciman processor - ReadA Overview: Version 1.1.0.2 and previous",
"product_id": "CSAFPID-0004"
}
}
],
"category": "product_name",
"name": "BD Kiestra TLA WCA InoqulA+ speciman processor - ReadA Overview"
},
{
"branches": [
{
"category": "product_version_range",
"name": "\u003c=3.0.0.0",
"product": {
"name": "PerformA: Version 3.0.0.0 and previous versions",
"product_id": "CSAFPID-0005"
}
}
],
"category": "product_name",
"name": "PerformA"
},
{
"branches": [
{
"category": "product_version_range",
"name": "\u003c=1.1.0.2",
"product": {
"name": "ReadA Overview: Version 1.1.0.2 and previous",
"product_id": "CSAFPID-0006"
}
}
],
"category": "product_name",
"name": "ReadA Overview"
}
],
"category": "vendor",
"name": "Becton, Dickinson and Company (BD)"
}
]
},
"vulnerabilities": [
{
"cve": "CVE-2018-10593",
"cwe": {
"id": "CWE-356",
"name": "Product UI does not Warn User of Unsafe Actions"
},
"notes": [
{
"category": "summary",
"text": "A vulnerability in DB Manager and PerformA allows an authorized user with access to a privileged account on a BD Kiestra system to issue SQL commands, which may result in data corruption.CVE-2018-10593 has been assigned to this vulnerability. A CVSS v3 base score of 5.6 has been calculated; the CVSS vector string is (AV:A/AC:H/PR:H/UI:R/S:U/C:N/I:H/A:H).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2018-10593"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:H/PR:H/UI:R/S:U/C:N/I:H/A:H"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "BD has developed a mitigation to prevent authorized users with access to a privileged account on a BD Kiestra system from triggering SQL functions. This mitigation also remediates a limited set of ePHI patient data that can be exposed when a privileged user executes a select SQL statement in the ReadA Overview. BD is in the process of deploying the mitigation remotely or on premise, depending on user preference.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Until mitigations are in place, BD recommends the following compensating controls. These controls require user action in order to reduce risk associated with these vulnerabilities:",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For product support or site-specific concerns, users in North America may contact Lab Automation Regional Phone Support via email lab_automation_phone_support@bd.com or by phone (1-800-638-8663). Users in EMEA may contact Customer Service Desk via email csd@bd.com or by phone (+31 512 540 623).",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For more specific details regarding these vulnerabilities, the associated mitigations, and links to user manuals, please see the BD Product Security Bulletin at the following location:",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "https://www.bd.com/en-us/support/product-security-and-privacy",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
],
"url": "https://www.bd.com/en-us/support/product-security-and-privacy"
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 5.6,
"baseSeverity": "MEDIUM",
"vectorString": "CVSS:3.0/AV:A/AC:H/PR:H/UI:R/S:U/C:N/I:H/A:H",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
}
]
},
{
"cve": "CVE-2018-10595",
"cwe": {
"id": "CWE-356",
"name": "Product UI does not Warn User of Unsafe Actions"
},
"notes": [
{
"category": "summary",
"text": "A vulnerability in ReadA allows an authorized user with access to a privileged account on a BD Kiestra system to issue SQL commands, which may result in loss or corruption of data.CVE-2018-10595 has been assigned to this vulnerability. A CVSS v3 base score of 6.3 has been calculated; the CVSS vector string is (AV:A/AC:H/PR:H/UI:R/S:U/C:H/I:H/A:H).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2018-10595"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:H/PR:H/UI:R/S:U/C:H/I:H/A:H"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "BD has developed a mitigation to prevent authorized users with access to a privileged account on a BD Kiestra system from triggering SQL functions. This mitigation also remediates a limited set of ePHI patient data that can be exposed when a privileged user executes a select SQL statement in the ReadA Overview. BD is in the process of deploying the mitigation remotely or on premise, depending on user preference.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Until mitigations are in place, BD recommends the following compensating controls. These controls require user action in order to reduce risk associated with these vulnerabilities:",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For product support or site-specific concerns, users in North America may contact Lab Automation Regional Phone Support via email lab_automation_phone_support@bd.com or by phone (1-800-638-8663). Users in EMEA may contact Customer Service Desk via email csd@bd.com or by phone (+31 512 540 623).",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For more specific details regarding these vulnerabilities, the associated mitigations, and links to user manuals, please see the BD Product Security Bulletin at the following location:",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "https://www.bd.com/en-us/support/product-security-and-privacy",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
],
"url": "https://www.bd.com/en-us/support/product-security-and-privacy"
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 6.3,
"baseSeverity": "MEDIUM",
"vectorString": "CVSS:3.0/AV:A/AC:H/PR:H/UI:R/S:U/C:H/I:H/A:H",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
}
]
}
]
}
Loading…
Loading…
Sightings
| Author | Source | Type | Date |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or observed by the user.
- Confirmed: The vulnerability has been validated from an analyst's perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
- Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
- Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
- Not confirmed: The user expressed doubt about the validity of the vulnerability.
- Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.
Loading…
Loading…